Navidea Biopharmaceuticals, Inc. Soared
Wed, Sep 13, 2023 at 07:21 PM

Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT) shot up at $0.12, representing a gain of 25.1%. On Wed, Sep 13, 2023, NAVB:NYSEMKT hit a New 2-Week High of $0.12. From Wed, Aug 30, 2023, the stock recorded 33.33% Up Days and 30.00% Green Days
About Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT)
Navidea Biopharmaceuticals Inc is a biotechnology company engaged in precision medicine. Its products are designed to assist in the identification of undetected diseases and develop treatment for cancer, autoimmune conditions, and inflammatory diseases.
Top 10 Gainers:
- Avalo Therapeutics Inc. (AVTX:NASDAQ), 81.13%
- ZyVersa Therapeutics Inc Com Stk (ZVSA:NASDAQ), 47.86%
- Impel NeuroPharma Inc. (IMPL:NASDAQ), 44.98%
- BitNile Metaverse Inc Com (New) (BNMV:NASDAQ), 44.31%
- Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ), 38.85%
- SRAX, Inc. (SRAX:NASDAQ), 33.33%
- DASAN Zhone Solutions, Inc. (DZSI:NASDAQ), 32.24%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 31.96%
- SHF Holdings Inc Cl A (SHFS:NASDAQ), 25.68%
- Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT), 25.13%